Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25811801 | 0.90 | KMT2A (0.61) | ALDH1A1KDM4EL3MBTL1KMT2ARAB9A | |
| SCHEMBL25811987 | 0.90 | KMT2A (0.58) | ALDH1A1KDM4EL3MBTL1KMT2ARAB9A | |
| SCHEMBL25811810 | 0.89 | TLR9 (0.48) | ALDH1A1KDM4EL3MBTL1KMT2ASMN1; SMN2 | |
| SCHEMBL25811806 | 0.89 | KMT2A (0.43) | ALDH1A1KDM4EL3MBTL1KMT2ARAB9A | |
| SCHEMBL25811965 | 0.82 | MAPT (0.52) | ALDH1A1KDM4EL3MBTL1KMT2ARAB9A | |
| SCHEMBL25811720 | 0.82 | KDR (0.49) | ALDH1A1KDM4EL3MBTL1KMT2ARAB9A | |
| SCHEMBL25811210 | 0.80 | KMT2A (0.70) | ALDH1A1KDM4EL3MBTL1KMT2ASMN1; SMN2 | |
| SCHEMBL25813827 | 0.79 | KDM4E (0.58) | ALDH1A1KDM4EKMT2ARAB9ANPC1 | |
| SCHEMBL25814053 | 0.79 | TLR9 (0.46) | ALDH1A1KDM4EKMT2ARAB9ANPC1 | |
| SCHEMBL25815032 | 0.79 | KMT2A (0.45) | ALDH1A1KDM4EKMT2ARAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218573-A1 | INDOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | GALYAN BIO INC (US) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218573-A1 | INDOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | HTT, HYPK, PARK7 | ALDH1A1 4430/4885KDM4E 1465/4885L3MBTL1 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.